Etanercept Therapy for Psoriasis in a Patient with Numerous Comorbidities

被引：2
|
作者：
De Simone, Clara [1 ]
Carbone, Angelo [1 ]
Caldarola, Giacomo [1 ]
机构：
[1] Policlin Univ, I-00168 Rome, Italy
来源：
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 2010年 / 11卷
关键词：
IDIOPATHIC DILATED CARDIOMYOPATHY; NECROSIS-FACTOR-ALPHA; EXPRESSION;
D O I：
10.2165/1153425-S0-000000000-00000
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
A recent study demonstrated an association between psoriasis and dilated cardiomyopathy. Tumour necrosis factor alpha (TNF alpha) may be involved in the pathogenesis of dilated cardiomyopathy and therefore, anti-TNF alpha agents may play a role in the treatment of dilated cardiomyopathy. The case of a 51-year-old woman with severe psoriasis and numerous comorbidities including dilated cardiomyopathy is described. During treatment with etanercept, the patient's psoriasis improved rapidly without any worsening of her other conditions. Etanercept was safe and effective in the treatment of severe psoriasis in a patient with numerous comorbidities, including dilated cardiomyopathy.
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [41] ETANERCEPT THERAPY IN PATIENTS WITH PSORIASIS AND CONCOMITANT HCV INFECTION
    Garavaglia, M. C.
    Altomare, G.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (03) : 965 - 969
  • [42] Etanercept therapy in psoriasis patients with underlying hepatitis C
    Allen, E
    Hurley, Y
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P1 - P1
  • [43] Etanercept in juvenile psoriasis [Etanercept in dertherapie der juvenilen psoriasis]
    Beikert F.C.
    Augustin M.
    Radtke M.A.
    Der Hautarzt, 2012, 63 (5): : 406 - 410
  • [44] Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory Study
    van Bezooijen, Ji Sun
    Balak, Deepak M. W.
    van Doorn, Martijn B. A.
    Looman, Caspar W. N.
    Schreurs, Marco W. J.
    Koch, Birgit C. P.
    van Gelder, Teun
    Prens, Errol P.
    DERMATOLOGY, 2016, 232 (04) : 407 - 414
  • [45] Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial
    Krueger, GG
    Langley, RG
    Finlay, AY
    Griffiths, CEM
    Woolley, JM
    Lalla, D
    Jahreis, A
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (06) : 1192 - 1199
  • [46] Patient-reported outcomes with etanercept therapy in patients with plaque psoriasis who lost response to adalimumab
    Papp, Kim A.
    Tyring, Stephen
    Stolshek, Bradley S.
    Rice, Kara Creamer
    Collier, David H.
    Kricorian, Greg
    Iles, Jan
    Kaliyaperumal, Arunan
    Bagel, Jerry
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB191 - AB191
  • [47] Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection
    Alcaide, A. J.
    Barrera, M. V.
    Habicheyn, S.
    Lopez, N.
    Mendiola, M. V.
    Herrera, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (12)
  • [48] Psoriasis, comorbidities and lifestyle: what is the patient's understanding of it?
    Foo, S. H.
    Stewart, G.
    Michelle, T.
    Ladoyanni, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 : 43 - 44
  • [49] Episode of Pustular Psoriasis After a Tuberculin Test in a Patient With Plaque Psoriasis on Treatment With Etanercept
    Guinovart, R. M.
    Ferrandiz, C.
    Bielsa, I.
    Carrascosa, J. M.
    ACTAS DERMO-SIFILIOGRAFICAS, 2011, 102 (10): : 828 - 830
  • [50] Treatment of Von Zumbusch pustular psoriasis in an HIV patient with etanercept
    Newman, Marissa
    Mikhail, Maryann
    Weinberg, Jeffrey
    Smith, Barry
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB123 - AB123
12345